Cite
Repurposing denosumab in lung cancer beyond counteracting the skeletal related events: an intriguing perspective
MLA
Maria V Deligiorgi, and Dimitrios T. Trafalis. “Repurposing Denosumab in Lung Cancer beyond Counteracting the Skeletal Related Events: An Intriguing Perspective.” Expert Opinion on Biological Therapy, vol. 20, July 2020, pp. 1331–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9d8b0cdbdea22dfe51fcd0264ab39140&authtype=sso&custid=ns315887.
APA
Maria V Deligiorgi, & Dimitrios T. Trafalis. (2020). Repurposing denosumab in lung cancer beyond counteracting the skeletal related events: an intriguing perspective. Expert Opinion on Biological Therapy, 20, 1331–1346.
Chicago
Maria V Deligiorgi, and Dimitrios T. Trafalis. 2020. “Repurposing Denosumab in Lung Cancer beyond Counteracting the Skeletal Related Events: An Intriguing Perspective.” Expert Opinion on Biological Therapy 20 (July): 1331–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9d8b0cdbdea22dfe51fcd0264ab39140&authtype=sso&custid=ns315887.